Brief: MedCap Announces Final Outcome In Its Recommended Cash Offer
27/12/2022 14:01
Dec 27 (Reuters) - AdderaCare AB ADDERA.ST :
* AT END OF INITIAL ACCEPTANCE PERIOD ON DEC 23 OFFER FOR
ADDERACARE SHARES HAD BEEN ACCEPTED BY SHAREHOLDERS REPRESENTING
ABOUT 94.57% OF SHARES
* SETTLEMENT FOR SHARES TENDERED IN OFFER DURING PERIOD
ENDING ON
23 DECEMBER 2022 IS EXPECTED TO COMMENCE AROUND 2 JANUARY 2023
* MEDCAP HAS DECIDED TO EXTEND ACCEPTANCE PERIOD UNTIL 9
JANUARY
2023
Source text for Eikon: ID:nWkr7LQDRS
Further company coverage: ADDERA.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))